NCT05416814已完成1 期
Safety and Feasibility of Kefir Administration in Critically Ill Adults
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- Feasibility of Kefir administration
研究概览
简要总结
The purpose of this study is to evaluate the safety and feasibility of kefir administration in critically ill adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Critically ill adult patients receiving antibiotics.
- •Functional GI tract (able to tolerate oral diet or tube feeding).
排除标准
- •Received antibiotics for >72 hours prior to enrollment.
- •Known immunosuppression (due to medications including chronic steroids, TNF-alpha inhibitors, monoclonal antibodies, immunosuppressive antimetabolites, etc.).
- •Compromised gut integrity (bowel resection, GI malignancy, GI bleed, inflammatory bowel disease).
- •History of CDI within 60 days.
- •Liver failure or pancreatitis.
- •Dairy intolerance or milk allergy.
- •Patients consuming probiotics at baseline.
- •Artificial heart valve.
- •Extremely poor prognosis and not expected to survive the treatment period.
研究组 & 干预措施
Kefir administration in critically ill adults
Experimental
Critically ill subjects will receive Kefir throughout the length of their ICU course in an ascending dosing regimen
干预措施: Kefir (Dietary Supplement)
结局指标
主要结局
Feasibility of Kefir administration
时间窗: 30 days
Number of subjects to have more than 75% of doses given when subject is allowed to have PO/feeding tube administration and are tolerated
Adverse Events
时间窗: 30 days
Number of adverse effects related to kefir administration including vomiting, aspiration, diarrhea, interactions with medications or tube feeds, bacteremia secondary to a bacterium in kefir
次要结局
未报告次要终点
研究者
Lioudmila Karnatovskaia
Principal Investigator
Mayo Clinic
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)Bone Marrow DiseaseNCT03773393Cellenkos, Inc.18
已完成
不适用
Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood PressureSide Effects of DrugsAdverse Drug EventNCT03112083Olympic Seafood AS35
暂停
早期 1 期
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)Posttraumatic Stress DisorderNCT06378528University of Wisconsin, Madison5
招募中
1 期
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414Ischemic StrokeNCT06525168Chendu DIAO Nine Hong Pharmaceutical Factory82
已完成
不适用
Open Label Study to Evaluate the Effect of Kaempferia Parviflora in Support of Erectile Function and Male Sexual HealthErectile FunctionNCT03389867Supplement Formulators, Inc.14